Retrophin, Inc. Underwriting Agreements

8 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Underwriting Agreement, dated November 7, 2024, by and among Travere Therapeutics, Inc., Jefferies LLC and Leerink Partners LLC
Underwriting Agreements
Retrophin, Inc.
2024
Underwriting Agreement, dated February 28, 2023, by and among Travere Therapeutics, Inc., Jefferies LLC, J.P. Morgan Securities LLC, BofA Securities, Inc. and SVB Securities LLC
Underwriting Agreements
Retrophin, Inc.
Biotechnology
NY
2023
Underwriting Agreement, dated March 8, 2022, by and among the Company, Jefferies LLC, SVB Securities LLC, BofA Securities, Inc. and Evercore Group L.L.C
Underwriting Agreements
Retrophin, Inc.
Biotechnology
NY
2022
Underwriting Agreement, dated February 11, 2021, by and among Travere Therapeutics, Inc., BofA Securities, Inc., Jefferies LLC and SVB Leerink LLC, as representatives of the...
Underwriting Agreements
Retrophin, Inc.
Biotechnology
NY
2021
Underwriting Agreement, dated June 8, 2020, by and among Retrophin, Inc., Jefferies LLC, Barclays Capital Inc. and BofA Securities, Inc., as representatives of the several...
Underwriting Agreements
Retrophin, Inc.
Biotechnology
NY
2020
Underwriting Agreement, dated September 5, 2018, by and among the Company, Jefferies LLC, and Barclays Capital Inc
Underwriting Agreements
Retrophin, Inc.
Biotechnology
2018
6,840,000 Shares RETROPHIN, INC. CommonStock, Par Value $0.0001 Per Share UNDERWRITING AGREEMENT
Underwriting Agreements
Retrophin, Inc.
Biotechnology
NY
2015
4,820,000 Shares Retrophin, Inc. UNDERWRITING AGREEMENT
Underwriting Agreements
Retrophin, Inc.
Biotechnology
NY
2014